Unizony, Sebastian <br/><br/>
Peripheral CD5+ B cells in antineutrophil cytoplasmic antibody-associated vasculitis.  [electronic resource] 

 -  Arthritis & rheumatology (Hoboken, N.J.)  Feb 2015 
 - 535-44 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2326-5205 
<br/><br/><label>Standard No.: </label>10.1002/art.38916  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis--drug therapy<br/>Antibodies, Monoclonal, Murine-Derived--therapeutic use<br/>Antirheumatic Agents--therapeutic use<br/>Azathioprine--therapeutic use<br/>B-Lymphocytes--immunology<br/>Biomarkers<br/>CD5 Antigens--metabolism<br/>Cell Count<br/>Cyclophosphamide--therapeutic use<br/>Disease Progression<br/>Double-Blind Method<br/>Drug Therapy, Combination<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Rituximab<br/>Treatment Outcome